MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14134580

Медицинская библиотека · Journal of clinical medicine · 2025

Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series.

Artosi Fabio, Cosio Terenzio, Diluvio Laura, Costanza Gaetana, Coniglione Filadelfo, Iacovantuono Maria, Matteini Enrico, Kaya Elif Çağla, Lambiase Sara, Bianchi Luca, Campione Elena

Клинический случайСтатьяПеревод в очереди

Аннотация

Background

Urticarial vasculitis (UV) is a rare form of small-vessel vasculitis characterized by persistent urticarial lesions and systemic manifestations. It differs from chronic spontaneous urticaria (CSU) both clinically and pathogenetically, often requiring systemic therapy. Despite its complexity, no standardized treatment algorithm exists.

Methods

We conducted a retrospective, monocentric, observational study on 11 patients diagnosed with UV at the Dermatology Unit of Tor Vergata University Hospital (Rome) between 2014 and 2024. Demographic, clinical, serological, and therapeutic data were collected from medical records. The therapeutic response was assessed using the Urticaria Control Test (UCT) score.

Results

The cohort comprised predominantly women (91%), with a mean age at diagnosis of 52.8 years. Autoimmune thyroiditis was the most frequent comorbidity (64%). Hypocomplementemia was detected in only one patient (9%), who also had systemic lupus erythematosus. Antihistamines, while usually prescribed, showed limited efficacy since none of the patients achieved complete remission with monotherapy. Systemic corticosteroids demonstrated rapid and effective control in acute phases. Omalizumab produced variable responses, with two patients achieving a high response (HR) and one reaching complete remission (CR). Methotrexate and cyclosporine yielded inconsistent outcomes. Due to the heterogeneity and limited sample size, statistical analyses were not performed.

Conclusions

UV presents with diverse clinical profiles and therapeutic responses. No treatment proved universally efficacious, but corticosteroids and omalizumab were effective in an acute and maintenance phase, respectively. Our findings underscore the importance of individualized treatment plans and the need for further studies to define predictive biomarkers and therapeutic strategies in UV.

Для цитирования: Artosi Fabio, Cosio Terenzio, Diluvio Laura, Costanza Gaetana, Coniglione Filadelfo, Iacovantuono Maria, Matteini Enrico, Kaya Elif Çağla, Lambiase Sara, Bianchi Luca, Campione Elena. Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14134580.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.